BackFidelity Select Biotechnology Portfolio Overview

Fidelity Select Biotechnology Portfolio Total Current Liabilities

Track Fidelity Select Biotechnology Portfolio's total current liabilities ($32M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$32.15M

Peer trimmed avg / median

Loading

Fidelity Select Biotechnology Portfolio Total Current Liabilities History

Loading

Fidelity Select Biotechnology Portfolio vs. peers: Total Current Liabilities Comparison

Loading

Fidelity Select Biotechnology Portfolio Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fidelity Select Biotechnology Portfolio (FBIOX) FAQ

As of the most recent data (October 2023), FBIOX shows a total current liabilities of $32M. Scroll down for historical charts and peer comparison views.

Tracking FBIOX's total current liabilities over time shows whether Fidelity Select Biotechnology Portfolio is scaling, shrinking, or reshaping that part of the business. The current reading is $32M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Fidelity Select Biotechnology Portfolio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $32M) with ownership activity and broader fundamentals.